Andreas Kluth, Bloomberg, Author at ACTSA

Vaccines: what about poor countries?

Rich countries have a lot of big decisions to make in coming weeks.

But these renunciation numbers are notoriously flawed.

If a vaccine is successfully developed who will get the chance to access it first?